Clinical Trials Browser

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

Carcinoma, Non-Small-Cell Lung, Colitis, Lung Neoplasms, Urogenital Neoplasms

Carcinoma, Hepatocellular

Lymphoma, Large B-Cell, Diffuse

Carcinoma, Non-Small-Cell Lung

Acute Graft Versus Host Disease

Gastrointestinal Neoplasms, Drug-Related Side Effects and Adverse Reactions

Colorectal Neoplasms

Breast Neoplasms

Solid Carcinoma

Pancreatic Ductal Adenocarcinoma

Carcinoma, Renal Cell

Carcinoma, Hepatocellular

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

Advanced Gastric Cancer

Constipation, Nausea, Vomiting

Carcinoma, Non-Small-Cell Lung

Carcinoma, Hepatocellular

Gastrointestinal Neoplasms

Non Small Cell Lung Cancer Metastatic

Leukemia, Myeloid, Acute

Hematologic Neoplasms

Lung Neoplasms

Colonic Neoplasms

Neoplasm Metastasis, Prostatic Neoplasms

Adenocarcinoma Of Esophagus

Solid Carcinoma

Mesothelioma

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Clinical Trials

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy

Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells

FMT-LUNG

Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation

A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects

Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders

FRIDA

Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.

NIVO-FMT

Fecal Microbial Transplants for the Treatment of Pancreatic Cancer

PERFORM

FLORA

MITRIC

Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer

FMT-NENs

Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection

Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy

FMT to Convert Response to Immunotherapy

Washed Microbiota Transplantation for the Treatment of Oncotherapy-Related Intestinal Complications

FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC

Fecal Microbiota Transplant (FMT) in Melanoma Patients

Fecal Microbiota Transplantation in Reversing Drug Resistance in Unresectable HCC (TALENP004)

Fecal Microbiota Transplant (FMT) Capsule for Improving the Efficacy of Anti- PD-1

FMT-LUMINATE

A Study of FMT in Patients With AML Allo HSCT in Recipients

FEMITGIGVHD

Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer

FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage

Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.

Study of FMT Combined With Nivolumab in Gastric Cancer

Utilization of Microbiome as Biomarkers and Therapeutics in Immuno-Oncology

A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma

Microtransplantation to Treat Refractory or Relapsed Hematologic Malignancies in Younger Patients